Erika Resetkova, M.D., PhD.
Department of Pathology, Division of Pathology and Laboratory Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1989 | Institute of Experimental Endocrinology, Bratislava, SVK, PHD, Physiology and Pathophysiology |
| 1984 | Medical Faculty of Comenius University, Bratislava, SVK, MD, Medicine |
Postgraduate Training
| 2003-2004 | Fellowship in Cytopathology, Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2002-2003 | Fellowship in Breast Pathology, Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2001-2001 | Fellowship in Breast Pathology, Prof. Paul P. Rosen, Department of Pathology and Laboratory Medicine, New York Weill Cornell Medical Center, New York, NY |
| 1999-2002 | Residency in Anatomic and Clinical Pathology, Department of Pathology and Laboratory Medicine, New York Weill Cornell Medical Center, New York, NY |
| 1998-1999 | Residency in Anatomic and Clinical Pathology, Department of Pathology and Laboratory Medicine, Strong Memorial Hospital, University of Rochester, Rochester, NY |
| 1996-1997 | Postdoctoral Fellowship, Department of Immunology and Rheumatology, Strong Memorial Hospital, University of Rochester, Rochester, NY |
| 1990-1996 | Postdoctoral Fellowship, Endocrinology Research Institute, University of Toronto, Toronto |
| 1986-1990 | Residency in Internal Medicine, Institute of Postdoctoral Education, Bratislava |
Board Certifications
| 2004 | Cytopathology Board, USA |
| 2002 | AP/CP Pathology Board, USA |
| 2000 | USMLE Step III |
| 1997 | USMLE Step II |
| 1997 | USMLE Step I |
| 1990 | Internal Medicine, Slovakia |
Honors & Awards
| 2009 | Awarded participation in Early Career Women Faculty Professional Development Seminar, Ritz Carlton Hotel, July 11-14 |
Selected Publications
Peer-Reviewed Articles
- Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic Correlation of Residual Mammographic Microcalcifications After Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer. Ann Surg Oncol 22(4):1111-7, 2015. e-Pub 2014. PMID: 25287438.
- Schuh F, Biazús JV, Resetkova E, Benfica CZ, Ventura Ade F, Uchoa D, Graudenz M, Edelweiss MI. Histopathological grading of breast ductal carcinoma In Situ: validation of a web-based survey through intra-observer reproducibility analysis. Diagn Pathol 10:93, 2015. e-Pub 2015. PMID: 26159429.
- Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology 62(2):267-74, 2013. e-Pub 2012. PMID: 22963676.
- Resetkova E. A Pictorial Journey Through Variants of Ductal Carcinoma in Situ (DCIS) and DCIS Mimickers. Clin Breast Cancer 12(5):347-63, 2012. PMID: 23040003.
- Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT. Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353-8, 2012. PMID: 22895267.
- Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169-77, 2011. e-Pub 2011. PMID: 21334720.
- Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 59(1):106-15, 2011. e-Pub 2011. PMID: 21668471.
- Lee YS, Mathew J, Dogan BE, Resetkova E, Huo L, Yang WT. Imaging Features of Micropapillary DCIS: Correlation with Clinical and Histopathological Findings. Acad Radiol 18(7):797-803, 2011. e-Pub 2011. PMID: 21419669.
- Resetkova E, Edelweiss M, Albarracin CT, Yang WT. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution. Breast Cancer Res Treat 127(2):335-43, 2011. e-Pub 2008. PMID: 18626769.
- Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J 16(6):573-80, 2010. PMID: 21070433.
- Schuh F, Biazús JV, Resetkova E, Benfica CZ, Edelweiss MI. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. Pathol Res Pract 206(10):705-11, 2010. e-Pub 2010. PMID: 20663616.
- Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 123(1):97-108, 2010. e-Pub 2009. PMID: 19911270.
- Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. e-Pub 2015. PMID: 25564996.
- Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow up. Chin J Cancer. e-Pub 2014. PMID: 24589208.
- Marian C, Boila A, Soanca D, Malau M, Podeanu DM, Resetkova E, Stolnicu S. Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature. APMIS. e-Pub 2012. PMID: 23030630.